⚙️ Technical Summary: Expanding Hovione’s Pharmaceutical Spray Drying Capacity
Hovione announced the opening of its new facility at its East Windsor, New Jersey site, doubling production capacity in the field of spray drying technology in the United States. The new site, which spans 31,000 square feet, includes two GMP-ready commercial units from PSD-3 spray dryers. This step strengthens the company’s global position as a leader in pharmaceutical manufacturing using this technology, and provides customers with an integrated path from active ingredient development to pharmaceutical product manufacturing.
The problem of limited aqueous solubility affects more than 70% of small drug molecules and is one of the main challenges in pharmaceutical development, and amorphous solid dispersions via spray drying come as an effective solution to improve bioavailability. Hovione relies on its more than a quarter-century of experience in this field to enable faster manufacturing processes and ensure their continuity.
🔥 The Latest Technologies in Pharmaceutical Spray Drying Systems
Industrial development in the new facility is based on the use of two PSD-3 spray dryers, which are commercial units built to GMP standards, allowing improved precision and consistency in the spray drying process while maintaining final drug quality.
The system operates within the current framework of FDA registration, and within unified quality standards across the campus, which helps facilitate technology transfer and reduce the time needed to scale up production. With this approach, customers can obtain greater manufacturing continuity and better product quality consistency.
Stages and Mechanisms for Improving Solubility Using Spray Drying
- Converting compounds with low aqueous solubility into amorphous solid dispersions amorphous solid dispersions.
- Using predictive modeling-based development tools to optimize drug formulations and manufacturing techniques.
- Applying integrated manufacturing expertise to speed up product development without losing active ingredient quality.
🏭 Growth and Expansion Strategy at the East Windsor Campus
The opening of 89 Twin Rivers marks the main achievement in a $100 million investment cycle in the United States. The future expansion plan includes developing an additional area of about 15 acres to build a new manufacturing facility of 125,000 square feet, including additional laboratories, spray drying equipment, and pharmaceutical product manufacturing facilities.
This step confirms Hovione’s long-term commitment to strengthening its industrial footprint in New Jersey, aiming to establish a development and manufacturing center for a new generation capable of supporting the growing demands of the pharmaceutical market, while providing jobs for about 80 people at the new site.
🔧 Global Integration and the Shift Toward Reliance on a Multi-Site Network
The East Windsor expansion supports the company’s global strategy, which focuses on creating an independent and unified network of sites across North America, Europe, and Asia in terms of quality and technologies.
This expansion was integrated with the announcement of recent additional investments in Portugal and Ireland, strengthening Hovione’s ability to achieve dual manufacturing strategies and more efficient regional distribution while improving supply chain flexibility.
Benefits of the Multi-Site Network:
- Reducing the risk of production stoppages by relying on alternative sites.
- Improving supply time and reducing industrial waste.
- Maintaining unified quality within integrated quality systems.
🚗 The Impact of These Expansions on the Mechanical Engineering and Pharmaceutical Development Sector
The importance of this achievement lies in providing innovative solutions to improve types of pharmaceutical formulations that face the challenge of limited aqueous solubility, which is one of the complex engineering and mechanical challenges in pharmaceutical manufacturing processes.
The application of an integrated manufacturing base from active molecules to the final product also supports work on spray drying systems, and enhances the role of mechanical engineering in designing and improving these systems in terms of efficiency, flow, and thermal control.
In addition, the development of large-scale facilities containing advanced systems reflects the industrial trend toward automation and improved pharmaceutical manufacturing processes, representing a valuable addition to the field of mechanical automation and industrial quality control.
🔥 In Conclusion: Strengthening Hovione’s Leadership in Pharmaceutical Manufacturing Using Spray Drying
Hovione’s expansion at the East Windsor site is an important turning point in the company’s history spanning more than twenty years in the United States, with a continued focus on technical innovation and advanced manufacturing.
This project highlights how mechanical engineering, represented by spray drying systems and modern manufacturing technologies, can play an effective role in confronting the challenges of the pharmaceutical industry, especially low-solubility products that require complex and advanced industrial solutions.
The investment in the infrastructure of this advanced technology also strengthens the company’s ability to serve a larger number of global customers, supporting the development of innovative pharmaceutical treatments quickly and with high quality that meets the needs of the market and patients around the world.
📚 Related articles
Discover more from Mohdbali
Subscribe to get the latest posts sent to your email.
